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ABSTRACT
Background: Animal models with various combination of host-parasite have long been employed
to study malaria pathogenesis. Here, we describe the combination of Plasmodium berghei ANKA infec-
tion in inbred ICR mice as a model of cerebral malaria (CM).
Methods: Infection in mice was initiated by intraperitoneal injection of 2 x 107 (0.2ml) parasitized
red blood cells (PRBCs).
Results: This model can produce a severe degree of infection presented by the high degree of
parasitaemia followed by death 6-7 days post infection. Severe anemia, splenomegaly, hepatomegaly
and discolourations of major organs were observed. Histopathological findings revealed several im-
portant features mimicking human CM including, microvascular sequestration of PRBCs in major
organs, particularly in the brain, hypertrophy and hyperplasia of the kupffer cells in the liver, pulmo-
nary edema and hyaline membrane formation in the lungs and haemorrhages in the kidney’s medulla
and cortex. Proinflammatory cytokines TNFα, IFNγ, IL-1, IL-6 and IL-18, and anti-inflammatory
cytokine IL-10 were all found to be elevated in the plasma of infected mice.
Conclusion: This model can reproduce many of the important features of CM and therefore can be
used as a tool to advance our understanding of the disease pathogenesis.
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Introduction
xperimental animal models have been
paramount towards the understanding
of human diseases. They represent the
first crucial step in the research of the underly-
ing disease pathogenesis and development of
new drug compounds and vaccines (1), and
had paved the way into a modern biomedical
research without which we would know very
little. Animals are employed as models of hu-
man diseases mainly due to the impossibility
of some research procedures to be carried out
in humans for practical or ethical reasons. De-
spite the limitations in mimicking every fea-
tures of the human disease, majority of the
current available knowledge basically relies on
animal model data. Many approaches to un-
derstanding pathogenesis of disease have in-
volved experimental animal model and in vitro
modelling of the pathogenic process. New
experimental animal models should be consid-
ered as an additional strength as they will un-
doubtedly bring advances in our knowledge
and understanding of human pathological
conditions, but their relevance must be pre-
cisely validated.
Malaria is undoubtedly still considered as the
most serious tropical disease that afflicts man-
kind throughout the world with the greatest
impact in the sub-saharan Africa. During 2010,
a total of 106 countries worldwide were consi-
dered as endemic of malaria with an estimated
3.3 billion people were at risk of the disease.
The disease burden in 2010 was estimated at
216 million cases with 655,000 estimated
deaths worldwide, in which, 86% were in chil-
dren under 5 years of age (2). The disease is
caused by protozoan parasite from the genus
Plasmodium (P.) with female Anopheles mosquito
acted as the vector. Four species of Plasmodium
are known to infect human, namely P. Ovale, P.
Vivax, P. Malariae and P. falciparum, with the
latest being the most virulent and lethal.
So far, malarial models have been developed
in monkey, rats and mice, and although they
cannot exactly mimic the full human syn-
drome of the disease, they do faithfully repre-
sent certain aspects of human malaria. The
mouse model has been extensively studied due
to the numerous similarities between the de-
fined malaria antigens in murine and human
parasites and also between the murine and
human immune response pathway. The many
species and strains of Plasmodium available and
the very large selection of inbred and outbreed
laboratory rodents has created a great number
of mouse-parasite combinations that can be
used experimentally. The most widely used
model of malaria so far is P. berghei ANKA
infection in CBA or C57BL/6 mice (3, 4).
In this study, we investigated the validity of
using P. berghei ANKA infection in ICR mice
as a model of severe malaria infection. Plasmo-
dium berghei ANKA strain is the parasite of
choice because of its ability to sequester with-
in the microcirculation which is the characte-
ristic of severe malaria especially the cerebral
form (5).
Cerebral malaria (CM), the major severe form
of the infection, is lethal and mainly resulted
from P. falciparum infection. It is characterized
by a sequestration of parasitized red blood
cells (PRBC), particularly in the deep cerebral
vascular beds and by elevated levels of pro-
inflammatory cytokines such as TNFα, IL-1,
IL-6, IFNγ etc. (6, 7). The fine mechanisms
leading to cerebral complications in human
CM remains incompletely understood and the
understanding of the pathogenesis of CM
necessarily relies on the use of experimental
animals or in vitro models (8). Analysis of cere-
bral pathology in human patients is almost
impossible and the full extent of the patho-
genic events leading to severe complications in
falciparum infection remains largely unresolved
since the outcome from post-mortem investi-
gation can only provide the endpoint findings.
The existing animal models of CM need to be
improved and their advantages and disad-
vantages must be systematically evaluated.
New model systems with new host-pathogen
E
Iranian J Parasitol: Vol. 7, No.4, 2012, pp. 62-74
64 Available at: http://ijpa.tums.ac.ir
combination and well defined parameters will
also need to be developed.
It is hopeful that the introduction of a new
model of malaria in this study with new com-
bination of mouse-parasite and well-defined
pathophysiological features that mimic the
human disease, will pave a way to a better un-
derstanding of the underlying processes lead-
ing to the severe manifestation and death in
severe malaria cases, especially CM.
Here, we describe the combination of P. berg-
hei ANKA infection in inbred ICR mice as a
model of cerebral malaria (CM).
Materials and Methods
Animals
This study was conducted at Universiti Putra
Malaysia from January 2011 till December
2011. Male ICR mice weighing initially be-
tween 18-20g were used in this study. The
mice were obtained from the Faculty of Medi-
cine & Health Sciences Animals Unit, Univer-
siti Putra Malaysia where they were maintained
at a constant room temperature (25-27 oC) on
a 12 hour light (0800-2000) and dark (2000-
0800) cycle with unlimited access to food
(CRM feeding pellets) and water. Animals
were handled as gently as possible and trans-
ferred from the Unit to the laboratory at least
30-60 min prior to use, in order to minimise
the effects of stress. All procedures conducted
on the animals were in accordance to the rules
and regulations set by the Animals Care and
Use Committee (ACUC) of Universiti Putra
Malaysia (Ethical approval number:
UPM/FPSK/PADS/BR-UUH/00365).
Parasite and infection procedures
The rodent malaria parasite, P. berghei ANKA
strain (chloroquine sensitive), was originally
obtained from The Institute of Medical Re-
search, Kuala Lumpur, Malaysia. The parasite
has been maintained at Universiti Putra Malay-
sia by combination of passage in male ICR
mice and cryoscopic storage. Serial passage of
P. berghei was initiated after storage at -70 C
by intraperitoneal (i.p) injection into normal
mice of 0.2ml blood containing parasites
stored in Alservers buffer solution and al-
lowed for 3 or 4 days depending on the devel-
opment of the parasites in the mice. Subse-
quent passage for maintaining the parasites
were carried out by i.p inoculation of normal
mouse with 0.2 ml blood, diluted to contain 2
x 107 parasitized red blood cells (PRBC) from
a donor mouse. Passage was repeated every
three or four days (with parasitaemia levels
reaching at least 35%). Parasitaemia was meas-
ured on the day of passage and 0.1ml mini-
mum of blood was removed from the infected
mouse by cardiac puncture while the animal
was under general anesthesia induced by inha-
lation of diethyl ether. Blood was diluted with
sterile, non-pyrogenic 0.85% saline to give 2 x
107 PRBC in an injection volume of 0.2ml and
the percentage parasitaemia determined the
amount of saline used in the dilution of the
infected blood (e.g., if 1ml of blood was re-
moved then dilution was with (x-1)ml of saline,
where x was the percentage parasitaemia). In-
fection in the experimental mice was carried
out by injecting 0.2 ml of 2 x 107 PRBC (i.p).
Control to the malarial mice received an
equivalent volume and dilution of normal un-
infected red blood cells.
Measurements of basic parameters
The body weight of mice was measured
throughout the study using a Shimadzu
(UX4200H) top pan animal balance to the
nearest 0.1g. Colonic temperature in mice was
measured using a BIOSEB (BIO9882) rectal
thermometer with a probe inserted approx-
imately 1.5 cm past the anal sphincter into the
colon of hand-held mice. All control and ma-
laria-infected mice were observed visually
throughout the experiment for behavioural
changes and signs of illness which include di-
arrhoea, lethargy, piloerection, and decreased
locomotor activity. Any signs of illness were
quantified using arbitrary scale and recorded
as either absent (-), mild (+), moderate (++)
or severe (+++). Infection in the mice was
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allowed to continue until all the infected mice
died of the infection. Mortality was recorded
throughout the experiment. Post mortem exami-
nations were carried out for any observable
changes in the appearance of the liver, spleen
and brain of both control and infected mice.
Parasitaemia measurement
A drop of blood was collected from the mice
by venesection of the tail and transferred onto
the edge of a microscope slide (single, 76 x 26
mm thickness). The blood was drawn evenly
across a second slide to make a thin blood
film and allowed to dry at room temperature
before staining with Leishman stain. Slides
were viewed using light microscopy (Vickers
Instruments) with oil immersion (1000x mag-
nification). Parasitaemia was counted based on
the Leishman positive bodies which represent
the parasitized red blood cells. The Leishman
positive cells were counted with the aid of a
graticule and hand counter. Five fields of ap-
proximately 200 cells each were counted and
the parasitaemia was calculated as the per-
centage of the total red blood cells containing
Leishman positive bodies.
Cytokines measurement in the plasma
Five major cytokines were measured in the
plasma of control and malarial mice which in-
clude the pro-inflammatory cytokines TNFα,
IFNγ, IL-1, IL-18 and IL-6 and the anti-
inflammatory cytokine IL-10. All the cytokines
were measured by means of ELISA method
using the commercially available kits (R&D
System, USA). The assay was carried out ac-
cording to the manufacturer’s procedures and
protocols. Blood samples for plasma were col-
lected from the mice by cardiac puncture
while they were terminally anaesthetised by
inhalation of diethyl ether. Blood was taken
using a sterile disposable syringe containing
0.05ml heparin (1000U/ml) and transferred
into a sterile non-pyrogenic glass test tube be-
fore centrifugation (MSE, Centaur 2) at 2500
rpm for 10 min to separate the plasma from
the blood cells.
Histopathological study
Five major organs including the brain, liver,
lungs, spleen and kidneys were collected from
the animals on day 5 post-infection and pre-
served in 10% of buffered formalin for
histopathological study. Organ collections
were carried out on day 5 post infection to
avoid losing the fresh organs due to the high
mortality rate of infected mice on day 6. The
organ specimens were subjected to a tissue
processing cycle using an automated tissue
processor (Leica, Germany) to remove the wa-
ter from the tissues. Following that, the speci-
mens were embedded into melted paraffin
wax using a histoembedder (Leica, Germany)
and sectioned into a 4.0µm thick slice with a
microtome (Leica, Germany). Tissue sections
were then stained with hematoxylin and eosin
(H&E) using an autostainer (Leica, Germany).
The morphological changes within the tissues
of the control and infected mice were ob-
served under light microscopy with 100x, 200x
and 400x magnifications.
Statistical analysis
Results were analysed statistically using Graph
Pad Prism software and SPSS version 16.
Group means from the experiment were com-
pared using one-way ANOVA (analysis of va-
riance) followed by Tukey’s test as a single
post-hoc test. All results are expressed as
mean  s.e.m (standard error of the means).
P<0.05 is taken as statistically significant.
Results
Parasitaemia development
Parasitaemia levels were taken as the percen-
tage of parasitized red blood cells measured.
In the malarial mice, an increase in parasitae-
mia with increasing days after inoculation were
observed with peak parasitaemia occurred on
day 6 (Fig. 1).
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Fig. 1: Parasitaemia measured in the control and
malaria-infected mice. Parasitized red blood cells
were taken as an index of parasitaemia. Results are
mean ± s. e. m with N=8, ***P<0.0005
Control mice on all days showed Leishman
positive cells between 1-2% and served as the
baseline. A high degree of parasitaemia was
observed in this species, peaking on day 6 (60-
80%). This model of malaria infection is lethal
and death would follow the peak parasitaemia.
20% mortality was recorded on day 5 post in-
fection, followed by 70% mortality on day 6
and by day 7, 100% mortality were observed
(Fig. 2).
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Fig. 2: Percentage survival of control and malaria
infected mice following inoculation with the para-
sites
Total count on the normal red blood cells
(RBCs) also showed a tremendous decrease in
the number with more than 70% reduction in
the total number of RBC during late critical
phase of the infection (Fig. 3).
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Fig. 3: Total red blood cells counted in the con-
trol and malaria-infected mice. Results are mean ±
s.e.m of N=8. ***P<0.0005
Basic parameters and visual observations
The overall mean values of body weight in the
malaria-infected mice were significantly de-
creased as compared to the control uninfected
group (Fig. 4).
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Fig. 4: Body weight of control and malaria-
infected mice. Results are mean ± s.e.m of N=8,
*P<0.05, ***P<0.0005
Control group progressively gain weight until
the end of the experiment on day 6 whereas a
progressive decrease in body weight was ob-
served in malarial mice. The average weight
gain in the control group was 0.73 ± 0.37g/day
whereas malarial infected group showed an av-
erage weight loss of 0.79 ± 0.36g/day. The
body temperature changes in both control and
malaria-infected mice measured as colonic
temperature are shown in Fig. 5.
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Table 1: Post mortem observations on five major organs in malaria-
infected mice
Organ Post-mortem observations
Spleen Enlargement of the size (splenomegaly);Discolouration of the spleen
Liver Enlargement of the size (hepatomegaly);Discolouration of the liver
Brain Paleness of the brain
Kidneys Discolouration of the kidneys
Lungs Discolouration of the lungs
Table 3: Physical signs of illness in control and malaria-infected
mice
Illness
behaviours
Days after
inoculation Control
Malaria-
infected
Piloerection
1 - -
2 - -
3 - -
4 - +
5 - ++
6 - +++
Lethargy
1 - -
2 - -
3 - -
4 - +
5 - ++
6 - +++
Reduction
in
locomotor
activity
1
2
3
4
5
6
-
-
-
-
-
-
-
-
-
+
++
+++
Passage of
dark urine
1 - -
2 - -
3 - -
4 - -
5 - ++
6 - +++
Indicator: (-) absent; (+): mild; (++): moderate; (+++): severe
Ta
ble
 2:
We
t w
eig
ht 
of 
fiv
e m
ajo
r o
rga
ns 
of 
con
tro
l an
d m
ala
ria
-in
fec
ted
 m
ice
Or
ga
n
Co
ntr
ol 
(m
g)
Ma
lar
ia-
inf
ect
ed
 m
ice
 (m
g)
Da
y 1
Da
y 2
Da
y 3
Da
y 4
Da
y 5
Da
y 6
Liv
er
843
+6
.66
854
.11
+4
.29
118
4.5
0+
8.4
5
138
4.6
7+
15.
24
145
1.3
3+
13.
66
156
2.7
2+
4.6
7
163
3.8
9+
6.2
5
Sp
lee
n
81.
56+
2.6
6
88.
83+
1.8
5
129
.28
+0
.96
150
.89
+1
4.7
3
156
.89
+2
.03
177
.06
+3
.12
202
.56
+2
.09
Bra
in
277
.44
+4
.92
312
.50
+4
.57
334
.17
+4
.56
348
.06
+5
.39
360
.33
+1
6.0
4
360
.44
+1
5.6
9
366
.17
+1
.48
Lu
ngs
150
.44
+2
.38
176
.06
+3
.24
180
.56
+2
.69
192
.39
+3
.28
208
.33
+4
.71
236
.00
+6
.68
253
.61
+1
1.5
3
Kid
ney
s
225
.00
+5
.55
259
.00
+5
.37
278
.78
+2
.68
283
.61
+0
.67
294
.39
+1
2.5
5
305
.17
+1
0.4
1
331
.06
+4
.91
Significant changes on body temperature in malaria-infected
mice were observed starting on day 4 following infection. A
gradual decrease in body temperature was observed with
body temperature fall as low as 32 °C on day 6 following in-
fection (Fig. 5).
Post mortem examinations on the internal organs revealed
the darkening of the liver, spleen, lungs and the kidneys of
the malaria-infected mice (Table 1).
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Fig. 5: Colonic temperature of control and malar-
ia-infected mice. Results are presented as the mean
± s.e.m of N=8, *P<0.05, **P<0.005,
***P<0.0005
Paleness of the brain was also observed in the
infected group as compared to the control.
Malarial mice also showed enlarged spleen and
liver indicating splenomegaly and hepatomeg-
aly respectively.  The wet weights of all the
organs recorded a gradually increased towards
the late stages of the infection as compared to
the controls (Table 2). Physical signs of illness
including piloerection, lethargy, decreased
locomotor activity and passage of dark/black
urine were observed during the late critical
stages of the infection (Table 3).
Cytokines levels in the plasma
In this malarial model, all the pro-
inflammatory cytokines, TNFα, IFNγ, IL-1,
IL-6 and IL-18 and the anti-inflammatory cy-
tokine IL-10, were significantly elevated in the
plasma throughout the infection with the
highest level recorded during the late critical
stage (Fig. 6).
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Fig: 6: Plasma concentrations of a) TNFα, b) IFNγ, c) IL-1, d)
IL-6, e) IL-18 and f) IL-10 of control and malaria-infected
mice. Results are mean ± s.e.m of N=8, ***P<0.0005
Relatively high levels of TNFα,
IFNγ, IL-1, IL-6 were recorded at
the early stage of infection and per-
sisted throughout. IL-10 increment
is more gradual with low levels rec-
orded at the start of infection and
then gradually increased towards the
later stages of infection. IL-18 was
only significantly elevated during
the middle and late phase of the
infection.
Histopathological findings
Histopathological findings showed
that sequestrations of PRBCs in the
microvasculature occurred in the
brain (Fig. 7B & C), lungs (Fig. 8C),
liver (Fig. 9Aii), spleen (Fig. 10D)
and kidney (Fig. 11B & D).
Apart from the sequestration of
PRBCs in the microvasculature,
some other important features of
severe malaria were also observed in
all the organs. In the brain, mild
petechial haemorrhages were ob-
served (Fig. 7D). The lungs from
infected mice showed features of
hyaline membrane formation which
may suggest haemorrhage (Fig.
8B(i)).
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The alveolar spaces of the lung were filled
with exudates in some areas which may clearly
indicates pulmonary edema (Fig. 8C).
Haemozoin accumulation occurred in the
parenchymals of the lungs (Fig. 8B(ii)) and
macrophages engulfing the pigments (Fig. 8C)
were observed. In the liver of malarial mice,
there were hyperplasia and hypertrophy of the
kupffer cells (Fig. 9B). The hepatocytes
showed vacuolar degeneration and focal atro-
phy (Fig. 9C (i)). Hyperaemia accompanied
with capillaries dilatation was also clearly ob-
served in the liver (Fig. 9E).
The spleen of malarial mice showed enlarge-
ment of the red and white pulps accompanied
by the lost of typical structure of the germinal
centre (Fig. 10B). Malaria pigments were wide-
ly seen in the pulp histiocytes and sinusoidal
lining cells (Fig. 10C) and also in the spleen
microvasculature (Fig. 10D). The kidney tis-
sues were presented with abundant of PRBC
and haemozoin in the microvasculature and
interstitium (Fig. 11B). Hyaline cast and
vacuolation in the tubules were occasionally
observed. Congestions and haemorrhages
were seen in the medulla (Fig. 11B) and cortex
(Fig. 11C & 11D) of the kidney of infected
mice.
Fig. 7: Haematoxylin-Eosin staining of brain tis-
sue showed sequestration of PRBCs in the cere-
bral microvessels (B) & (C) as compared to the
normal uninfected mice (A). Petechial haemor-
rhages were also observed in the cerebral tissue
(D). Specimens were examined under light micros-
copy at 400x magnification
Fig: 8: Hyaline membrane formation due to alveo-
lar haemorrhage (B (i)) was seen in the lung tissue
of malaria-infected mice as compared to the nor-
mal uninfected animal (A). Accumulation of ma-
larial pigment, haemozoin, were also observed (B
(ii)), and the alveolar was congested with macro-
phages engulfing pigments (C). Viewed under light
microscopy at 400x
Fig: 9: In the liver of malaria-infected mice, hy-
perplasia and hypertrophy of kupffer cells (A(iii))
with vacuolar degeneration and atrophy of hepato-
cytes (A(i)) were observed as compared to unin-
fected mice (C). Microvascular congestion with
PRBCs also occurred (A(ii)) leading to congestion
of the blood vessels in the liver. Hyperaemia were
observed accompanied with capillaries dilatation
(B). Viewed under light microscopy at 400x mag-
nification
A B
C
A B
C
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Fig: 10: In the spleen of mice infected with malar-
ia, the red and white pulp elements were enlarged
accompanied by the lost of typical structure of the
germinal centre (B), which is comparable to the
normal uninfected mice (A). Accumulation of ma-
larial pigments, haemozoin, was obvious in the
pulp histiocytes and sinusoidal lining cells (C).
Microvascular sequestrations of PRBCs were also
present (D). Viewed under light microscopy at
100x (A & B) and 400x (C & D) magnification
Fig. 11: The medulla tissues of the kidney
from infected mice were presented with wide-
spread sequestration of PRBCs in the
microvascular and interstitium (B), compared
to the normal uninfected mouse (A). Haemor-
rhages (C, D(i)) and congestion (D(i)) of the
cortex with PRBCs were also observed.
Viewed under light microscopy at 400x
(A,B,D) and 200x (C) magnification
Discussion
Approaches to understanding disease patho-
genesis have involved experimental infections
in animal model and in vitro modelling of the
pathogenic processes. In the study of CM,
both the experimental animal and in vitro mod-
els have been central to our understanding of
the events leading to cerebral pathology. CM
is a major lethal complication of P. falciparum
infection in human which involved an ex-
tremely complex multi-process and multi-
system disorder presenting a wide range of
clinical features. It is characterized by a se-
questration of PRBC as the main important
feature, particularly in the deep cerebral mi-
crovasculature and by the increased levels of
pro-inflammatory cytokines. Prospective stud-
ies on the relationship between the immuno-
logical events and the neurological dysfunc-
tion and also other pathophysiological param-
eters in human are clearly unethical. Therefore,
experimental animal models are necessary to
unscramble the fatal pathogenic processes.
Data obtained in this study substantiated that
ICR mice are very susceptible to P. berghei
ANKA infection. Rapid onset of malaria oc-
curred as early as on day 1 following inocula-
tion with the parasite. A high degree of
parasitaemia with ultimate death suggests the
severe degree of infection in this model.
Death is also the ultimate complication of
many falciparum cases in human. Massive lost
in the total number of normal RBC in this
model showed a characteristic sign of severe
anaemia which is one the major clinical mani-
festation of severe malaria in human. The
pathogenenesis of severe anaemia during ma-
laria infection is complex and involves multi-
ple processes relating to both the destruction
and decreased production of erythrocytes (9).
During falciparum infection, reticulocyte levels
are low (10), indicating the suppression of
erythropoietin synthesis. Increased RBCs de-
struction also occurs through the rupture of
PRBCs and the phagocytosis of the parasitized
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and unparasitized RBCs by the hyperactive
macrophages in the reticuloendothelial system
(10, 11). Severe anaemia has been identified as
one of the main mechanisms of severe mor-
bidity and mortality in falciparum infection
since it can lead to profound hypoxia and
congestive cardiac failure (12, 13).
In this study, we measured the body weights
of the infected mice to monitor the effects of
infection on factors such as food and water
intake, metabolism and gut function. The de-
crease in body weight of malarial mice was
clearly evident from the third day of infection,
and presumably due in part to the decrease in
food intake. Decrease in body weight may also
be the consequences of disturbed metabolic
function and hypoglycaemia that has been re-
ported to be associated with malaria infection
(2). Records on body temperature during the
study showed that the mice developed hypo-
thermia upon infection with the parasites. Fe-
ver is one of the dramatic manifestations of
human malaria.  In contrast, this model of ma-
laria was associated with hypothermia rather
than pyrexia. The infected mice developed
profound hypothermia with colonic tempera-
ture falling by as much as 9 C. The prolonged
development of severe hypothermia in mice
can be attributed to the general debilitating
effects of malaria on the host, which results in
the lost of body heat and eventual death. The
absence of pyrogenic response in this model is
due to the fact that small animals like mice
have a large surface area-to-body mass ratio,
which resulted in a higher degree of heat loss
and prevents the development of fever caused
by pyrogenic agents (14). Decreased food in-
take, indicated by decreased body weight, may
also have contributed towards hypothermia.
Changes in the physical appearances of vital
organs in the body are common during malar-
ia infection. Splenomegaly and hepatomegaly
are among the common phenomena (15, 16).
Both organs are congested and swollen from
the accumulation of the malarial pigment,
haemozoin, which led to discolouration. In
kidney, congestion can occur in the cortex and
medulla during falciparum infection (17). Pale-
ness of the brain may be resulted from the
severe anemia. Piloerection, one of the physi-
cal signs of illness observed in this model, may
be related to the hypothermic state during the
infection as the homeostatic mechanism is
adapting to the heat loss. The passage of dark
urine in this model may be equalized with the
blackwater fever normally occur in falciparum
malaria (18, 19).
Inflammatory cytokines have long been impli-
cated in severe malaria. In this model of ma-
laria, all the inflammatory cytokines (TNFα,
IFNγ, IL-1, IL-6, IL-18, IL-10) were found to
be significantly elevated in the systemic circu-
lation. Similar observations in the elevation of
these cytokines levels have been made in hu-
man malaria. Findings from the previous stud-
ies have revealed the possible role played by
each cytokines in the pathogenesis of malaria.
Plasma levels of TNFα studied in patients
with severe falciparum infection showed a sig-
nificant elevation of the cytokine which often
correlates with the cerebral pathology (20, 21,
22). TNFα was thought to be the crucial final
mediator of inflammation in CM, but its pro-
duction is regulated by other pro-
inflammatory cytokines including IFN and
IL-12. IFNγ has been associated with both the
pathogenesis and protection against human
malaria (23, 24). For IL-6, even though the
level is elevated during CM, but it is not
thought to be directly involved in the patho-
genesis of the disease (25). IL-10 is an
immunoregulatory cytokines and has been as-
sociated with the amelioration of the patholo-
gy and death in murine malaria (26). In chil-
dren with severe malaria, elevated levels of IL-
10 have been reported to play protective role
(27, 28). IL-18 is quite a newly identified cyto-
kines among the six reported in this study, but
its involvement in malaria infection have been
documented in a few studies. IL-18 was found
to be highly elevated in this model of malaria,
especially during the late critical stages of the
infection. Prior study in human have revealed
a similar finding in which elevated IL-18 levels
Iranian J Parasitol: Vol. 7, No.4, 2012, pp. 62-74
72 Available at: http://ijpa.tums.ac.ir
were observed in patients with falciparum ma-
laria and the levels were significantly higher in
severe group as compared to the uncomplicat-
ed group (29), with positive correlation ob-
served between IL-18 and the extent of
parasitaemia.
Since malaria causes multi-organs dysfunction,
we carried out a histopathological study on
five major organs known to be affected during
malaria infection i.e., the brain, liver, spleen,
lungs and kidneys. In human, sequestration of
PRBCs in vital organs of the body, particularly
in the brain, heart, lungs and liver is a major
feature of severe malaria due to infection with
P. falciparum. Sequestration of PRBC within
the brain is the major histopathological feature
of human CM. It was suggested that CM is a
consequence of the adherence of PRBC to the
cerebral microvascular endothelium, leading to
vascular obstruction and cerebral hypoxia (5).
Sequestrations of PRBC in the microvascula-
ture of all the major organs were also ob-
served in this model of malaria. A few other
features mimicking those seen during CM
were also observed. In the lungs, hyaline
membrane formations suggesting hemorrhag-
es occurred which may lead to ineffective gas
exchange through the alveolar membrane.
Pulmonary edema was also present which is
an important feature of severe malaria and the
most dangerous complication of falciparum in-
fection (30, 31). In the liver, macrophages en-
gulfed the PRBCs causing lysis of the blood
cells leaving behind the haemozoin deposited
in the parenchymals. The same histopatholo-
gy-ical features were observed in the liver dur-
ing falciparum infection in human (32). Sple-
nomegaly observed on the spleen of infected
mice in this model also mimic the conditions
of falciparum infection in human, in which,
splenomegaly is a common phenomenon with
the spleen becomes congested with malaria
haemozoin caused by an increase of the pulp
element rendering trabeculae and follicles in-
distinct (16). Histopathological features of the
kidney tissue in this model like hyaline cast
and vacuolation in the tubules and also con-
gestions and haemorrhages of the kidney’s
medulla and cortex, are also typical
histopathological features of falciparum infec-
tion in human (17).
Conclusions
We have demonstrated in this study that P.
berghei ANKA infection in ICR mice can re-
produce many of the important clinical fea-
tures of human CM. Therefore, this model
can be used to further advance our knowledge
and understandings of the pathogenesis of
CM and can also be utilized as the first step in
the screening of potential new compounds or
vaccine candidates to treat severe malaria like
CM.
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